article thumbnail

Bibliometric analysis of youth myocardial infarction research (1980–2023)

Frontiers in Cardiovascular Medicine

IntroductionCardiovascular diseases include myocardial infarction, a high mortality disease. Myocardial infarction patients are becoming younger, typically defined as patients under 45 years of age. We searched the WoSCC between 1980 and 2023 for research papers and reviews on myocardial infarction in youth.

article thumbnail

Prognostic implications of stress test-induced arrhythmias: a systematic review and meta-analysis

Open Heart

Methods Relevant studies examining arrhythmia in both exercise and pharmacological stress testing were searched for in PubMed, Embase and Cochrane databases from inception to 14 June 2023. However, it is linked to subsequent diagnosis of AF, coronary artery disease and myocardial infarction.

article thumbnail

Association between trimethylamine N-oxide and prognosis of patients with myocardial infarction: a meta-analysis

Frontiers in Cardiovascular Medicine

Therefore, this meta-analysis aimed to estimate association between TMAO levels and the prognosis of patients with myocardial infarction (MI).MethodsWe MethodsWe searched PubMed, EMBASE, the Cochrane Library, and Web of Science from inception to July 2, 2023, to retrieve all relevant clinical trials.

article thumbnail

Stress hyperglycemia and poor outcomes in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Background Hyperglycemia, characterized by elevated blood glucose levels, is frequently observed in patients with acute coronary syndrome, including ST-elevation myocardial infarction (STEMI). Results The 66 included articles spanned the years 2005–2023. Most studies defined STEMI with primary PCI as their inclusion criteria.

article thumbnail

Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 05 December 2023; doi:10.1038/s41569-023-00974-z Author Correction: Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction

article thumbnail

Electroacupuncture for slow flow/no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention: protocol for a pilot randomized controlled trial

Frontiers in Cardiovascular Medicine

BackgroundSlow flow/no-reflow (SF-NR) during percutaneous coronary intervention (PCI) is associated with poor prognosis of patients with acute myocardial infarction (AMI). Registered on 8 June 2023. Currently, effective treatment is not available for SF-NR.

article thumbnail

Role of lymphocyte-to-C-reactive protein ratio in forecasting microvascular obstruction in ST-segment elevation myocardial infarction post-percutaneous coronary intervention

Frontiers in Cardiovascular Medicine

BackgroundCurrent research suggests that microvascular obstruction (MVO) following the first percutaneous coronary intervention (PCI) in myocardial infarction patients is closely related to inflammatory responses. However, the relationship between LCR and MVO remains unclear.